Novavax (NVAX) Misses Q4 EPS by 1c
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $3.97 +2.06%
EPS Growth %: +72.1%
Financial Fact:
Loss from operations: -63.31M
Today's EPS Names:
MAXN, CSTR, ACU, More
EPS Growth %: +72.1%
Financial Fact:
Loss from operations: -63.31M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q4 EPS of ($0.13), $0.01 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $6.1 million versus the consensus estimate of $7.09 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- Synovus Financial (SNV) PT Lowered to $42 at Piper Sandler
- Wipro (WIT) Tops Q1 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
